Success Metrics

Clinical Success Rate
100.0%

Based on 26 completed trials

Completion Rate
100%(26/26)
Active Trials
0(0%)
Results Posted
12%(3 trials)

Phase Distribution

Ph phase_2
1
4%
Ph phase_1
24
89%
Ph phase_3
2
7%

Phase Distribution

24

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution27 total trials
Phase 1Safety & dosage
24(88.9%)
Phase 2Efficacy & side effects
1(3.7%)
Phase 3Large-scale testing
2(7.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

96.3%

26 of 27 finished

Non-Completion Rate

3.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

27

all time

Status Distribution
Completed(26)
Terminated(1)

Detailed Status

Completed26
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
27
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 124 (88.9%)
Phase 21 (3.7%)
Phase 32 (7.4%)

Trials by Status

completed2696%
withdrawn14%

Recent Activity

Clinical Trials (27)

Showing 20 of 27 trialsScroll for more
NCT07305831Phase 1

A Clinical Trial to Evaluate the Effect of Ulonivirine (MK-8507) on Heart Rhythm in Healthy Adults (MK-8507-012)

Completed
NCT01689116Phase 1

Multiple-Dose Study of Effect of Bardoxolone Methyl on QT/QTC Interval Volunteers

Completed
NCT05804162Phase 1

A Research Study Looking at How Cagrilintide Works on the Heart Rhythm in Healthy Participants

Completed
NCT06258265Phase 1

A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements

Completed
NCT06070597Phase 1

A Study in Healthy People to Test Whether Iclepertin Has an Effect on Cardiac Safety

Completed
NCT05818852Phase 1

A Study to Evaluate the Effect of VX-548 on the QT/QTc Interval in Healthy Participants

Completed
NCT05867147Phase 1

An Electrocardiogram Study to Evaluate the Effect of Vanzacaftor on the QT/QTc Interval in Healthy Participants

Completed
NCT00779532Phase 1

Thorough QT/QTc Study of Multiple Oral Doses of NOMAC-E2 (Org 10486 0 + Org 2317) in Healthy Women (Study 292011)(P05802)

Completed
NCT00789568Phase 1

A Phase 1 Study to Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult Subjects

Completed
NCT01518699Phase 1

Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers

Completed
NCT04688632Phase 1

Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects

Completed
NCT01516372Phase 1

A Study to Evaluate the Effect of Gabapentin on Cardiac Repolarization in Healthy Volunteers

Completed
NCT03696459Phase 1

A Study to Evaluate the Effect of JNJ-53718678 on the Cardiac Repolarization Interval in Healthy Adult Participants

Completed
NCT02307864Phase 1

Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants

Completed
NCT01069900Phase 3

Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection

Completed
NCT02515864Phase 2

Clinical Pharmacology of FYU-981 (Effect on QT/QTc Interval)

Completed
NCT02257398Phase 1

Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers

Completed
NCT01209026Phase 1

Corrected QT (QTc) Study With Flucticasone Furoate and GW642444

Completed
NCT01756495Phase 1

A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin

Completed
NCT02104648Phase 1

A 2-Part Study to Evaluate the Safety of Supra-Therapeutic Doses of RO4602522 and to Investigate the Effect of RO4602522 on the QTc Interval

Completed

Drug Details

Intervention Type
DRUG
Total Trials
27